Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0016848 POLYMER, COMPOSITION, COATING FILM, LAYERED PRODUCT, BACK SHEET, AND SOLAR CELL MODULE
Provided is a polymer capable of providing a coating film that has good initial adhesiveness to a base material and good adhesiveness thereto after a pressure...
2019/0016847 CURABLE POLYFARNESENE-BASED COMPOSITIONS
A polymer having a hydrophobic polymer chain derived from monomers of farnesene and other optional monomers, such as dienes and vinyl aromatics. The polymer...
2019/0016846 POLYMERIZABLE COMPOSITION
A polymerizable composition comprising a) at feast one cyclic amide, b) from 2.8 to 3.5% by weight, preferably from 2.9 to 3.1% by weight, of at least one...
2019/0016845 Method For Providing Surface Modifying Composition With Improved Byproduct Removal
A method forming a surface modifying composition with reduced need for organic solvent and evaporation thereof for removal of insoluble reaction byproducts...
2019/0016844 DELAYED ACTION GELLING CATALYST COMPOSITIONS AND METHODS FOR MAKING POLYURETHANE POLYMERS
Additives for making polyurethanes are disclosed. The additives are based on combining specific carboxylic acids or carboxylic di-acids together with a gelling...
2019/0016843 PHOSPHORYLATED POLYCONDENSATE AS HIGH EFFICIENCY WATER REDUCING AGENT AND PREPARATION METHOD THEREOF
The present invention discloses a phosphorylated polycondensate high-performance water-reducing agent with a phosphorylated melamine derivative, instead of a...
2019/0016842 Hydrogenated Copolymer, Composition, and Molded Article
A hydrogenated copolymer comprising a copolymer block A comprising a vinyl aromatic compound monomer unit and a conjugated diene monomer unit, wherein a tan...
2019/0016841 METHOD OF PREPARING ABS-BASED RESIN COMPOSITION AND METHOD OF MANUFACTURING ABS-BASED INJECTION-MOLDED ARTICLE...
The present invention relates to a method of preparing an ABS-based resin composition and a method of manufacturing an ABS-based injection-molded article...
2019/0016840 LIQUID REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION, AND METHOD FOR PRODUCING OIL RESISTANT PAPER
To provide a liquid repellent composition whereby a treated article excellent in liquid repellency is obtainable, which is excellent in stability and does not...
2019/0016839 (METH) ACRYLATE POLYMERS
(Meth)acrylate polymers are provided which have a narrow molecular weight distribution on a higher molecular weight side and can impart high shear viscosity...
2019/0016838 Method For Preparing Acrylic Copolymer, Acrylic Copolymer And Resin Composition Comprising The Copolymer
Provided is a method for preparing an acrylic copolymer, and more specifically, provided are a method for preparing an acrylic copolymer including: i) adding...
2019/0016837 RHEOLOGY-MODIFYING AGENTS FOR SLURRIES
The present disclosure relates to rheology-modifying agents and methods of modifying the rheology of slurries. A rheology-modifying agent may be added to a...
2019/0016836 COPOLYMERS OF PERFLUOROTRIVINYLTRIAZINE COMPOUNDS AND METHODS FOR SYNTHESIZING THE COPOLYMERS
Provided herein are copolymers that comprise copolymerized residues of a perfluorotrivinyltriazine monomer of Formula 1. ##STR00001## Preferred R.sub.f groups...
2019/0016835 PROCESS CONTROL FOR LONG CHAIN BRANCHING CONTROL IN POLYETHYLENE PRODUCTION
Polymerization process control methods for making polyethylene are provided. The process control methods include performing a polymerization reaction in a...
2019/0016834 CATALYST COMPONENT FOR THE PREPARATION OF NUCLEATED POLYOLEFINS
Catalyst composition comprising a phthalate-free electron donor, which is highly effective during polymerisation in the presence of a polymeric nucleating...
2019/0016833 Process for Cross-Linked Polyethylene Production
A method of producing a silane cross-linked polyethylene is disclosed which includes maleating a polyethylene polymer to form a maleated polyethylene and...
2019/0016832 NON-PHTHALATE CATALYST SYSTEM AND ITS USE IN THE POLYMERIZATION OF OLEFINS
This invention relates to a non-phthalate catalyst system for olefin polymerization. The non-phthalate catalyst system comprises (a) a solid Ziegler-Natta...
2019/0016831 GAS PHASE POLYMERISATION OF ETHYLENE
The invention relates to a process for the production of polyethylene by gas phase polymerisation of ethylene in the presence of a supported chromium oxide...
2019/0016830 METHOD FOR DEACETYLATION OF BIOPOLYMERS
A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2)...
2019/0016829 SYSTEMS AND METHODS FOR DEWATERING A SLURRY THAT INCLUDES LIGNOCELLULOSIC BIOMASS AND LIQUID
The present disclosure relates to a dewatering systems, and related methods, that are adapted to convey lignocellulosic biomass to separate at least a portion...
2019/0016828 FC-REGION VARIANTS WITH MODIFIED FCRN- AND MAINTAINED PROTEIN A-BINDING PROPERTIES
Herein is reported a polypeptide comprising a first polypeptide and a second polypeptide each comprising in N-terminal to C-terminal direction at least a...
2019/0016827 METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE
Herein is reported a method for determining the binding interaction with a multimeric antigen of an antibody of the human IgG1 subclass that has at least two...
2019/0016826 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
The invention provides anti-HtrA1 antibodies and methods of using the same.
2019/0016825 PCSK9 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF
The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a...
2019/0016824 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a living subject. The methods comprise the...
2019/0016823 ANTI-CD3 ANTIBODIES AND METHODS OF USE
The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.
2019/0016822 SELF-CROSSLINKING ANTIBODIES
Provided are self-crosslinking meditope-enabled antibodies. Also provided are methods for altering the distribution of a cell surface antigen using ...
2019/0016821 STABILIZED PEPTIDE FRAGMENTS FROM PROTOCADHERIN FAT1 AS CANCER BIOMARKERS
An embodiment of the invention relates to the use of stabilized cancer peptide fragments derived from Protocadherin FAT1 for the diagnosis of cancers,...
2019/0016820 CHIMERIC CYTOKINE RECEPTOR
The present invention provides a chimeric cytokine receptor (CCR) comprising: (i) an exodomain which binds to a ligand selected from a tumour secreted factor,...
2019/0016819 ANTI-CD20 COMBINATIONS FOR TREATING TUMORS
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.
2019/0016818 ANTIBODIES AGAINST GLYPICAN-3 AND THEIR USES IN CANCER DIAGNOSIS AND TREATMENT
The present invention relates to anti-GPC3 antibodies and their applications. The invention investigates the potential inhibitory effect of anti-GPC3...
2019/0016817 BUFFERED FORMULATIONS OF BEVACIZUMAB
The invention provides buffered aqueous formulations of bevacizumab. The formulations comprise a citrate phosphate buffer comprising trehalose or sucrose, and...
2019/0016816 ONCOFETAL ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS
The present disclosure relates to protein molecules that specifically bind to 5T4 and/or 4-1BB. The molecules may have at least one humanized 5T4-binding or...
2019/0016815 ANTI-ENDOGLIN ANTIBODIES AND USES THEREOF
The present application relates to compositions of humanized and deimmunized anti-endoglin antibodies and antigen-binding fragments thereof. One aspect relates...
2019/0016814 ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF
The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies...
2019/0016812 NOVEL ANTI-TNFSF9 ANTIBODIES AND METHODS OF USE
Provided are novel anti-TNFSF9 antibodies and antibody drug conjugates, and methods of using such anti-TNFSF9 antibodies and antibody drug conjugates to treat...
2019/0016811 ANTI-GARP PROTEIN AND USES THEREOF
The present invention relates to a protein binding to GARP in the presence of TGF- and uses thereof.
2019/0016810 METHODS FOR TREATING OR PREVENTING GRAFT-VERSUS-HOST DISEASE INVOLVING THE ADMINISTRATION OF ANTI-CCR5 RECEPTOR...
The present invention provides for inhibition or blockade of immunomodulatory cell receptors to treat or prevent graft-versus-host disease (GVHD). Thus, the...
2019/0016809 CXCR2 ANTIBODIES AND USES THEREOF
The invention relates to CXCR2, to antibodies and related fragments thereof for binding to CXCR2, to production of said antibodies and fragments and to use of...
2019/0016808 ANTI-EGFR COMBINATIONS FOR TREATING TUMORS
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.
2019/0016807 ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE
The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell...
2019/0016806 ANTI-PD-1 ANTIBODIES AND USES THEREOF
A subset of humanized anti-PD-1 antibodies that inhibit binding of PD-L1 and PD-L2 to human PD-1. These binding proteins modulate the immune system through the...
2019/0016805 ANTIBODY CONSTRUCTS FOR CDH19 AND CD3
The present invention provides to a antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target...
2019/0016804 DUAL SPECIFICITY POLYPEPTIDE MOLECULE
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding...
2019/0016803 DUAL SPECIFICITY POLYPEPTIDE MOLECULE
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding...
2019/0016802 DUAL SPECIFICITY POLYPEPTIDE MOLECULE
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding...
2019/0016801 DUAL SPECIFICITY POLYPEPTIDE MOLECULE
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding...
2019/0016800 ANTIBODIES BINDING LAG-3 AND USES THEREOF
The present invention provides an isolated monoclonal antibody that specifically binds LAG-3. A nucleic acid molecule encoding the antibody, an expression...
2019/0016799 HUMAN PROGRAMMED CELL DEATH 1 RECEPTOR ANTIBODY, METHOD OF PREPARING SAME, AND USE THEREOF
Disclosed are a human programmed cell death 1 receptor (hPD-1) antibody, a method of preparing the same, and use thereof. The preparation method comprises...
2019/0016798 ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF
The present invention relates to a neutralising antibody which is capable of binding to neurotensin with high affinity. The antibody of the present invention...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.